Alcohol Dependence
Àwòrán tí AI ṣe
New study offers hope for weight loss drugs against alcoholism
Ti AI ṣe iroyin Àwòrán tí AI ṣe
A new study from the University of Gothenburg shows that tirzepatide, the active ingredient in the diabetes and weight loss drug Mounjaro, reduces alcohol intake and relapse-like behaviors in rats and mice. This builds on prior research on semaglutide in Ozempic and Wegovy, which curbs alcohol consumption in humans. Researchers hope for similar effects in patients with alcohol dependence.